Strength
12.5 mg/1
Manufacturer
AvPAKNDC
50268040415
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203561On Market Since
12/8/2022
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has been published 164 times since May 10, 2023, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0284 per EA |
|---|---|
| All-time high | $0.0341 (Jan 10, 2024) |
| All-time low | $0.0263 (Jul 17, 2024) |
| 52-week high | $0.0306 |
| 52-week low | $0.0284 |
| Median price | $0.0301 |
| Average price | $0.0304 |
| Largest weekly change | +21.9% (Aug 21, 2024) |
| Weeks tracked | 164 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG CP, manufactured by AvPAK, is $0.0284 per EA (NDC 50268040415), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG CP changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has declined 5.4%. It has been tracked across 164 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG CP?
Since May 10, 2023, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has ranged from a low of $0.0263 (Jul 17, 2024) to a high of $0.0341 (Jan 10, 2024), with a median of $0.0301 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG CP?
9 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROCHLOROTHIAZIDE 12.5 MG CP, but none are currently priced below it.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG CP?
HYDROCHLOROTHIAZIDE 12.5 MG CP (NDC 50268040415) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification